Skip to content
10-K

Annual Report

ISTA PHARMACEUTICALS INC

0001193125-12-081708

← back to feed
Filed
Feb 27, 2012 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding FY 2011 · Jan 31, 2012 41.77M sh
Capex FY 2011 · Dec 31, 2011 $1.91M
Capex FY 2011 · Dec 31, 2010 $3.44M
Capex FY 2011 · Dec 31, 2009 $1.32M
Operating Cash Flow FY 2011 · Dec 31, 2011 −$3.49M
Operating Cash Flow FY 2011 · Dec 31, 2010 $28.1M
Operating Cash Flow FY 2011 · Dec 31, 2009 $3.99M
Cash And Equivalents FY 2011 · Dec 31, 2011 $71.59M
Cash And Equivalents FY 2011 · Dec 31, 2010 $78.78M
Cash And Equivalents FY 2011 · Dec 31, 2009 $53.7M
Cash And Equivalents FY 2011 · Dec 31, 2008 $48.32M
Stockholders Equity FY 2011 · Dec 31, 2011 −$49.07M
Stockholders Equity FY 2011 · Dec 31, 2010 −$79.1M
Stockholders Equity FY 2011 · Dec 31, 2009 −$78.03M
Stockholders Equity FY 2011 · Dec 31, 2008 −$17.2M
Current Liabilities FY 2011 · Dec 31, 2011 $137.85M
Current Liabilities FY 2011 · Dec 31, 2010 $106.04M
Total Liabilities FY 2011 · Dec 31, 2011 $202.16M
Total Liabilities FY 2011 · Dec 31, 2010 $213.34M
Current Assets FY 2011 · Dec 31, 2011 $140.12M
Current Assets FY 2011 · Dec 31, 2010 $121.86M
Total Assets FY 2011 · Dec 31, 2011 $153.09M
Total Assets FY 2011 · Dec 31, 2010 $134.24M
Sga Expense FY 2011 · Dec 31, 2011 $89.58M
Sga Expense FY 2011 · Dec 31, 2010 $82.63M
Sga Expense FY 2011 · Dec 31, 2009 $56.38M
Rd Expense FY 2011 · Dec 31, 2011 $31.63M
Rd Expense FY 2011 · Dec 31, 2010 $25.93M
Rd Expense FY 2011 · Dec 31, 2009 $24.9M
Net Income FY 2011 · Dec 31, 2011 −$56.61M
Net Income FY 2011 · Dec 31, 2010 −$5.3M
Net Income FY 2011 · Dec 31, 2009 −$57.75M
Operating Income FY 2011 · Dec 31, 2011 $19K
Operating Income FY 2011 · Dec 31, 2010 $10.36M
Operating Income FY 2011 · Dec 31, 2009 $2.09M
Gross Profit FY 2011 · Dec 31, 2011 $121.22M
Gross Profit FY 2011 · Dec 31, 2010 $118.92M
Gross Profit FY 2011 · Dec 31, 2009 $83.37M
Cost Of Revenue FY 2011 · Dec 31, 2011 $39.11M
Cost Of Revenue FY 2011 · Dec 31, 2010 $37.61M
Cost Of Revenue FY 2011 · Dec 31, 2009 $27.28M
Revenue FY 2011 · Dec 31, 2011 $160.33M
Revenue FY 2011 · Dec 31, 2010 $156.53M
Revenue FY 2011 · Dec 31, 2009 $110.65M